CF Pharmtech Rises Over 5% at Midday After Completing Placement of 21.7 Million New H Shares

Deep News08-13

CF Pharmtech (02652) saw its stock price surge more than 5% by midday, trading at HKD 16.94, up 5.15%, with a turnover of HKD 85.31 million.

The company announced that it had completed the placement of 21.7477 million new H shares on August 6, 2026, at a placing price of HKD 13.82 per share, raising net proceeds of approximately HKD 295 million.

According to the company's previous disclosure, about 70% of the net proceeds will be allocated to clinical and preclinical development of the group's innovative drug candidates. Approximately 15% will be used for CMC research, clinical studies, device development, and registration and regulatory filing expenses for the group's complex inhalation products worldwide, including CF048, CF059/CF060, CF066 EDS, CF067, CF068, and CF011/CF088.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment